SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

EVEREST ORGANICS

BSE: 524790 28 Jun 2025
Healthcare
₹ 328
Everest Organics Ltd. specializes in Pharmaceuticals within the Healthcare sector.

EVEREST ORGANICS - Share Price & Details

Market Cap
₹391.0
High /Low
477.0 / 112.0
Stock P/E
NA
Book Value
₹72.0
Dividend Yield
0.0
ROCE
1.76
ROE
₹-2.23
Face Value
10.0
PEG Ratio
NA
EVEBITDA
₹54.6
Debt
47.9
CMP / FCF
-452.0
Debt to equity
₹0.68
NP Ann
-1.29
High price all time
477.0
Piotroski score
₹2.0
Graham Number
NA
No. Eq. Shares
0.97
Net CF
₹5.82
Net profit
-1.29
Price to book value
5.59
Interest Coverage
₹0.38
Low price all time
12.5
Industry PE
33.8
Reserves
₹60.2
Free Cash Flow
₹-10.8

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
LOOKS HEALTH SERVICES LIMITEDNANANANA5.11256.0
Triochem Products Ltd.,NANANANA0
EVEREST ORGANICS LTD.NANANANA391.0
Fredun Pharmaceuticals LimitedNANANANA38518.5
ZENOTECH LABORATORIES LTD.NANANANA37781.9

Peer Comparison Chart


About EVEREST ORGANICS

Everest Organics Ltd., with Security Code 524790, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

EVEREST ORGANICS Share Price Today Down 5%

(19 Jun 2025)
EVEREST ORGANICS share price has plunged 5% and is presently trading at Rs 329.5. Meanwhile, the BSE HEALTHCARE index is at 42,893.0 (down...
Read more →

Everest Organics Adjusts Evaluation Amid Mixed Technical Indicators and Market Performance Challenges

(19 Jun 2025)
Everest Organics, a microcap in the Pharmaceuticals & Biotechnology sector, has recently adjusted its evaluation, indicating a shift in its market stance.
Read more →

Everest Organics Faces Intense Selling Pressure Amid Consecutive Losses and Market Shift

(14 Jun 2025)
Everest Organics Ltd is experiencing significant selling pressure, with the stock declining over the past three days.
Read more →

Is Everest Organics overvalued or undervalued?

(12 Jun 2025)
As of May 29, 2025, Everest Organics is considered overvalued with a valuation grade of "expensive," highlighted by a negative PE ratio of -319.92 and an EV...
Read more →

Has Everest Organics declared dividend?

(07 Jun 2025)
Everest Organics Ltd has declared a 5% dividend, amounting to 0.5 per share, with an ex-date of September 15, 2022. Despite the dividend declaration,...
Read more →

Who are in the management team of Everest Organics?

(07 Jun 2025)
As of March 2023, the management team of Everest Organics includes S K Hari Krishna (Whole-time Director), A Parvatisem (Director - Technical),...
Read more →